Oak Street Health Inc
F:HE6
Relative Value
There is not enough data to reliably calculate the relative value of HE6.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
HE6 Competitors Multiples
Oak Street Health Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
O
|
Oak Street Health Inc
F:HE6
|
1.6B EUR | 0.9 | -3.7 | -5.7 | -5.2 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
96.1B USD | 0.2 | 204.9 | 13.6 | 13.6 | |
| US |
|
Cigna Corp
NYSE:CI
|
77.3B USD | 0.3 | 12.5 | 0 | 0 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
64.7B EUR | 0.3 | 12.4 | 7.9 | 10.1 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
28B EUR | 1.3 | 24.4 | 10.7 | 16.2 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.6B EUR | 1.2 | 32.7 | 10.3 | 22.1 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.5B USD | 1.7 | 27.6 | 14.8 | 20.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.7B USD | 2.1 | 24 | 12.9 | 17.5 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.6B EUR | 0.6 | 16 | 6.4 | 13.6 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
13.2B USD | 14.6 | -33.1 | -34.9 | -31.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
9.6B USD | 0.7 | 12.8 | 7 | 9.5 |